Korean Journal of Ophthalmology · 1997 · 43 citations · 6 references
MedicineNeurologyOphthalmologyNeuro-ophthalmologyOcular DiseaseOcular PharmacologyNeuro-ophthalmic DisordersOcular ToxicologyOptic NeuropathiesRetinal ExaminationVisual ImpairmentVisual Loss EvaluationAdverse Ocular EffectsCentral Scotoma EvaluationDrug-induced Ocular ToxicityEthambutol ToxicityOcular Drug ToxicityOcular Toxicity AssessmentOphthalmic Drug SafetyVisual Acuity Impairment
Ethambutol is a useful first line antituberculous drug, but can cause significant visual impairment. In order to determine the clinical manifestations of optic neuropathy associated with ethambutol, and the margin of drug safety in Koreans, we investigated ten men and four women, diagnosed between 1995 and 1997 at Seoul Municipal Boramae Hospital as suffering from ethambutol toxicity. After determining their history, including the period during which ethambutol had been administered, and its dose, a complete eye examination was performed, including measurement of best-corrected visual acuity, pupillary examination, color vision, fundus examination and a test of visual field. Ocular ethambutol toxicity was observed at a dose as low as 12.3 mg/kg. Abnormal ophthalmic findings include decreased visual acuity and abnormal visual field, especially in the central scotoma, and abnormal color perception. In conclusion, ethambutol at a low dose can cause optic neuropathy, and for the early detection of this, a color vision test is important.
6
Peripheral Neuropathy Associated with Ethambutol
Vijayachandran S. Nair, Michel Lebrun, Irving Kass · CHEST Journal · 1980 · 48 citations
Medicine, Neurology, Pharmacotherapy +12
ETHAMBUTOL AND THE EYE; ZINC AND COPPER
I. A. Campbell · The Lancet · 1975 · 18 citations